FDA Inspection
San Diego Blood BankSan Diego Blood Bank – FDA Inspection, Jul 12, 2013
Record Details
This FDA Inspection record concerns San Diego Blood Bank, with an inspection on July 12, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- San Diego Blood Bank
- Inspection Date
- July 12, 2013
- Product Type
- Biologics
View Company Profile
ID · e1916a7c-aa02-47da-b148-30678dd88855
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 840220
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of San Diego Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 24, 2025 | Not classified | Los Angeles District Office | |
| August 5, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 28, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 31, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 13, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for San Diego Blood Bank
- FDA Inspection 1263923 - 2025-02-24
- FDA Inspection 1148693 - 2021-08-05
- FDA Inspection 1066189 - 2018-08-28
- FDA Inspection 970190 - 2016-03-31
- FDA Inspection 743860 - 2011-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.